跳至主要内容
临床试验/NCT01585779
NCT01585779已完成不适用

Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial

Medtronic Cardiovascular3 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2012年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
64
试验地点
3
主要终点
Change in the Degree of Tricuspid Regurgitation

研究概览

简要总结

The purpose of this study is to gather clinical information on the hemodynamic performance of the Contour 3D® and Tri-Ad® Tricuspid Annuloplasty Rings in a post-market environment.

详细描述

The primary goal of the TV repair procedure is to relieve patients from TV insufficiency or reduce TV stenosis. This study will evaluate the hemodynamic efficacy of the Contour 3D® and Tri-Ad® ring and characterize the effect of the TV repair through assessment of right atrial size and right ventricular function. Additionally, this study will characterize the patient population for whom a Contour 3D® or Tri-Ad® ring is chosen to repair TV insufficiency. Health status and adverse events (AE) will be assessed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject or legal guardian willing and able to sign and date the Informed Consent Form (and Authorization to Use and Disclose Health Information Form, if applicable)
  • Subject indicated for a concomitant surgical repair of the TV
  • Subject is willing to return for required follow-up visits to the hospital where the implantation originally occurred

排除标准

  • Subject with a degenerative TV condition
  • Subject with primary TV regurgitation
  • Subject with a previous TV repair or replacement
  • Subject indicated for a stand-alone TV repair
  • Subject currently participating in an investigational drug or another device study
  • Subject with life expectancy of less than one year
  • Subject is pregnant or desires to be pregnant within 12 months following implantation
  • Subject is under 18 or over 85 years of age
  • Subject with active endocarditis
  • Subject with valvular retraction with severely reduced mobility
  • Subject with a heavily calcified TV

结局指标

主要结局

Change in the Degree of Tricuspid Regurgitation

时间窗: Preimplant through 12 Months

The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment. Degree of TV regurgitation - Change in the degree of tricuspid regurgitation from preimplant through 12 months postimplant.

The Mean Gradient Across the Tricuspid Valve

时间窗: 12 months

The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the mean gradient across the tricuspid valve. The mean gradient across the tricuspid valve measured at discharge, 6 months, and 12 months post-implant

Change in the Degree of TV Leaflet Coaptation Length

时间窗: Preimplant through 12 Months

The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the TV leaflet coaptation length. Change in the degree of TV leaflet coaptation length from preimplant through 12 months postimplant.

Change in the Degree of TV Leaflet Tethering Height

时间窗: Preimplant through 12 Months

The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the TV leaflet tethering height. Change in the degree of TV leaflet tethering height from pre-implant through 12 months post-implant

次要结局

  • Demographic Data(Baseline)
  • Change in the RV Fractional Area(Preimplant through 12 Months)
  • Change in the Tricuspid Annular (Basal) Diameter(Preimplant through 12 Months)
  • Change in New York Heart Association (NYHA) Classification .(Preimplant through 12 months)
  • Change in the Right Ventricle (RV) Diastolic Area(Preimplant through 12 Months)
  • Change in New York Heart Association (NYHA) Classification(Preimplant through 6 months)

研究者

发起方
Medtronic Cardiovascular
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验

Contour 3D®/TriAd® Tricuspid Annuloplasty Ring... | 临床试验